Tiresia: You Still Ain't Seen Nothing Yet

My friends

Tiresias had made it his mission to explain Optiscan technology, and the application of the technology that Optiscan has brought forth. Thus far he has expounded the three main early applications, the low hanging fruit; namely, neurosurgery, oral cancer, and breast cancer. He will continue to expand on these areas. He also plans to discuss all the other applications, and for toady he had thought about discussing skin cancer surgery, cervical cancer, or bladder cancer. However, today, after last week’s tectonic shifts, Tiresias cannot go past commenting on coming aboard of Richard Chandler and the Clermont Group as the cornerstone investor in Optiscan. This changes everything

First, Tiresias would like to ask you, his friends, why would a billionaire invest in Optiscan? To make more few million dollars? Of course not. To make a Disallowed? To make a 10-fold return on the $9 million they invested? Okay, so $9 million in Optiscan becomes $90 million, and our billionaire in Singapore, who is worth well over $3 billion gets has a little but meaningless rise in his net worth. So what! Does he need another $90 million? Of not. To one worth $3 to $4 billion, $80 million is small change. Well, of course, even billionaires like to increase their wealth, but with his track record and connections, he could this sitting in Singapore, whilst sipping a Singapore Sling. It is therefore not just the money! You see my friends, when billionaires comes to a certain stage in life, they can continue accumulating money, and become ridiculous parodies, looked to for something meaningful, something that will make a real impact, something to really change the world.

Tiresias is sure that Richard Chandler has understood that Optiscan can be a vehicle to really change the world. He has the money, the connections, he has the reach, he has the wherewithal to finally get Optiscan into the clinics and the operating theatres around the world and really change cancer treatment. Of course, in the process he will make a meaningful increase to his current net worth. He sees all of this, for why else would he bother. He doesn’t think he could do better, from all the potential investments that are constantly brought to him, and Optiscan could not have done better. They now have a cornerstone investor who will not sell on a mere rise or even a tenfold increase in share price. They have a cornerstone investor which will bring in many followers. The medical technology analysts know nothing and can't analyse anything but when they see who has gone into this, many will follow. These followers, who are too frightened and ignorant to do anything original, can immediately justify their investment by pointing to whom they're in with.

So, my friends, the Clermont group brings a lot more than just money and third-party validation to Optiscan. Do not underestimate the power and the reach of Clermont group. They will add a new board member to strengthen greatly the very hard-working board and CEO, who saved Optiscan and managed to strike this paradigm shifting deal. Doors will open everywhere, in Asia in, in Australia, in New Zealand, in China, in America, in Europe, and around world. Truly, you still ain't seen nothing yet.